These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 22560147)
1. Cutaneous immunity and autoimmunity. Alam R Immunol Allergy Clin North Am; 2012 May; 32(2):xi-xii. PubMed ID: 22560147 [No Abstract] [Full Text] [Related]
2. What is new in autoimmune vesicobullous disorders? Mahajan R; De D Indian J Dermatol Venereol Leprol; 2011; 77(4):407-12. PubMed ID: 21727687 [No Abstract] [Full Text] [Related]
3. Intravenous immune globulin in autoimmune and inflammatory diseases. Gelfand EW N Engl J Med; 2012 Nov; 367(21):2015-25. PubMed ID: 23171098 [No Abstract] [Full Text] [Related]
4. [Auto-immune blistering diseases: a unique expertise in clinical research]. Joly P Ann Dermatol Venereol; 2011 Mar; 138(3):169-71. PubMed ID: 21397146 [No Abstract] [Full Text] [Related]
6. Rituximab and its use in autoimmune bullous disorders. Daniel BS; Murrell DF; Joly P Immunol Allergy Clin North Am; 2012 May; 32(2):331-7, viii. PubMed ID: 22560146 [TBL] [Abstract][Full Text] [Related]
7. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process]. Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636 [No Abstract] [Full Text] [Related]
8. The use of intravenous immunoglobulin in autoimmune bullous diseases. Chee SN; Murrell DF Immunol Allergy Clin North Am; 2012 May; 32(2):323-30, viii. PubMed ID: 22560145 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune diseases of the skin. Murrell DF Immunol Allergy Clin North Am; 2012 May; 32(2):xiii-xiv. PubMed ID: 22560148 [No Abstract] [Full Text] [Related]
11. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease. Czernik A Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786 [No Abstract] [Full Text] [Related]
12. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Venning VA Immunol Allergy Clin North Am; 2012 May; 32(2):245-53, vi. PubMed ID: 22560137 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update. Czernik A; Toosi S; Bystryn JC; Grando SA Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613 [TBL] [Abstract][Full Text] [Related]
14. Perspectives in immunoregulation and autoimmunity. Cruse JM; Lewis RE Concepts Immunopathol; 1986; 3():1-16. PubMed ID: 3496159 [No Abstract] [Full Text] [Related]
15. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy. Kneisel A; Hertl M J Dtsch Dermatol Ges; 2011 Nov; 9(11):927-47. PubMed ID: 22026362 [TBL] [Abstract][Full Text] [Related]
17. Private and public coverage policies for rituximab in the treatment of immunobullous disease in the United States. Bloom R; Amber KT J Am Acad Dermatol; 2015 Aug; 73(2):337-8. PubMed ID: 26183986 [No Abstract] [Full Text] [Related]